\
&
Contact us
Published on | 3 months ago
Programmes Health Digital, Industry & Space Climate, Energy, Mobility EITWhat is it about ?
The Global Outreach Initiative of the European Institute for Innovation and Technology (EIT) wants to help starting entrepreneurs to embark on a global journey and conquer new markets. The next possible destination is Japan and the EIT has set-up a business training programme "Calling2Scale Gunma: gateway to Japan 2025". It is a collaboration with the Gunma Prefecture Governor's office.
This training is open to European startups (including Horizon Europe Associated countries) in these key sectors:
What will the startups get?
The application deadline is the 15th of September 2025 and you can find the registration details here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.